These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 206626)

  • 21. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and control of bovine enzootic leukosis. 4. Comparison of antibody formation following inoculation of the Riems concentrated foot-and-mouth disease vaccine in clinicially healthy and in pre-leukotic cattle].
    Seils H; Wittmann W; Weyhe D
    Arch Exp Veterinarmed; 1971 Jun; 25(3):581-6. PubMed ID: 4330772
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.
    Pay TW; Hingley PJ
    Vaccine; 1987 Mar; 5(1):60-4. PubMed ID: 3033928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A blastogenic test for foot-and-mouth disease.
    Wardley RC; Chapman WG; Garland AJ
    J Hyg (Lond); 1979 Dec; 83(3):507-12. PubMed ID: 229161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological response of cattle to simultaneous vaccinations against foot-and-mouth disease and haemorrhagic septicaemia.
    Joseph PG; Hedger RS
    Vet Rec; 1984 May; 114(20):494-6. PubMed ID: 6330961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1989 Jun; 102(6):193-8. PubMed ID: 2548473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.
    Lavoria MÁ; Di-Giacomo S; Bucafusco D; Franco-Mahecha OL; Pérez-Filgueira DM; Capozzo AV
    Vaccine; 2012 Nov; 30(48):6845-50. PubMed ID: 23000129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine.
    Park ME; You SH; Lee SY; Lee KN; Ko MK; Choi JH; Kim B; Lee JS; Park JH
    J Vet Sci; 2017 Aug; 18(S1):323-331. PubMed ID: 28859272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
    Ackermann M; Müller HK; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of vaccine strains of foot and mouth disease virus for use in southern Africa.
    Fargeaud D
    Rev Sci Tech; 1995 Sep; 14(3):521-38. PubMed ID: 8593387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three variants of foot-and-mouth disease virus type O: exposure of cattle.
    Sutmoller P; McVicar JW
    Am J Vet Res; 1972 Aug; 33(8):1641-7. PubMed ID: 4340054
    [No Abstract]   [Full Text] [Related]  

  • 39. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge.
    Donaldson AI; Kitching RP
    Res Vet Sci; 1989 Jan; 46(1):9-14. PubMed ID: 2537993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.